Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma - Université de Lorraine Access content directly
Journal Articles Leukemia Year : 2013

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

Dates and versions

hal-01707019 , version 1 (12-02-2018)

Identifiers

Cite

H Tilly, F. Morschhauser, G. Salles, R-O Casasnovas, P Feugier, et al.. Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma. Leukemia, 2013, 27 (1), pp.252 - 255. ⟨10.1038/leu.2012.172⟩. ⟨hal-01707019⟩
36 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More